AbbVie

Biological Research Associate II

Posted on: 1 Apr 2021

Irvine, CA

Job Description

About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Envision working with energetic colleagues and inspirational leaders. Now, place yourself in that mix; leading discussions, asking the right questions and driving results.

What Your New Manager Wants You To Know

Allergan Aesthetics is seeking a highly motivated and innovative candidate for the role of Biological Research Associate II. The successful candidate for this position will contribute to projects aimed at pharmacological characterization of protein-based therapeutics. Under supervision by senior personnel, he/she will be required to work on a variety of in vivo animal pharmacology models to help characterize and evaluate biological compounds. This individual will need to organize, analyze and interpret results, come forward with recommendations and present the findings to senior personnel or in team meetings. Experience in handling and injecting rodents is required. Experience with histological, as well as other laboratory techniques is a plus. The successful candidate may collaborate extensively with other Research Associates and Scientists, while taking personal responsibility for success of assigned tasks and projects.

Furthermore, the position requires the individual to work with and in areas requiring select agents and Toxins access (i.e. Biosafety level 2 and biosafety level 3 laboratories). Access to and use of select agents is regulated by federal policies. Therefore, the candidate must conduct all work activities in compliance with AbbVie internal and applicable regulatory requirements. AbbVie internal requirements include compliance with ethics, environmental health and safety, financial, human resources, and general business policies, requirements and objectives.

YOU ARE more than just a title, YOU ARE

* First class team player: collaborate across multiple disciplines to ensure compliance and ability to influence cross-functional teams and senior leadership.

You Will

* Plan, design and execute in vivo pharmacological studies focused on motor, autonomic and sensory nervous system function, and potentially some in vitro assays. Formulation and dilution of large protein molecules.
* Conduct data analysis and prepare presentations to multidisciplinary teams.
* Work with cross-functional team members to accomplish the goals and requirements of the organization, including excellence in execution, and workload prioritization.

LI-PD1

Qualifications
You Bring

* Bachelor-level education in biological science field plus 2+ years' experience in either academic or industry laboratory setting.
* Experience with performing a variety of rodent in vivo behavioral and/or pharmacological assays.
* Experience with small animal handling, dosing of molecules through a variety of different routes and post-mortem tissue harvest is required.
* Experience with histological techniques, including immunohistochemistry and microscopy techniques, as well as other laboratory techniques is a plus.
* Good writing and communication skills are required.
* Computer skills: working knowledge of MS-Office (Excel, Word, PowerPoint) is required. Knowledge of graphing software (e.g., GraphPad prism) and basic understanding of statistical analyses is a plus.

In this role, we're looking for a leader who will:

* Act as an Owner
* Be Excellence Focused
* Act as an Influencer

Significant Work Activities
N/A
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.

AbbVie

Chicago, IL

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.

Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.